Gastric cancer or dysplasia

1. Type III intestinal metaplasia is associated with gastric cancer or dysplasia in humans (Pooled relative risk 6.27 versus type I/II intestinal metaplasia).

   “the sulfomucin-expressing type III subtype shows an even stronger association with cancer/dysplasia, with a pooled relative risk of 6.27 compared with type I/II IM.”

   ReviewCompared with type I/II intestinal metaplasiagastric mucosa

   Biomarkers for risk stratification of malignancy-prone precancerous conditions: focusing on gastric intestinal metaplasia

   Medical review (2021)·Jul 28, 2026

More on Type III intestinal metaplasia